NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/03/2026
Back to search
Official data from USPTO
A
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
02/04/2026
Trademark type
Combined
Nice classes
5, 10, 42, 44
Filing date
12/07/2021
Registration date
02/03/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/03/2026
Last transaction
02/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/28/2025
First use in commerce
07/28/2025
Drawing code
5
Owner type
03
Owner location
Toronto, Ontario, CA
Examiner
BRECKENFELD,WILLIAM G
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design reminiscent of a stylized lower case "a".
Holders and representatives
Holders
ADELA CANADA, INC.
Representatives
Ryan S. Hilbert HOLLEY & MENKER, PA
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying advanced analytics; Medical diagnostic tests comprised of assays and reagents that test for the presence of medical biomarkers present in human blood and body fluids by applying machine learning technology; Diagnostic assaysreagentsnucleotides for medical or clinical purposes
Class 10
Blood collection kit comprised of blood collecting tubes; Blood testing apparatus; Diagnostic apparatus for medical purposesdiagnostic kits consisting primarily of probesbuffers and reagents for use in liquid biopsy testing; Diagnostic tests comprising medical apparatus and instrumentsliquid biopsy testing systems; Medical diagnostic testing kits containing sterile medical specimen collection tools in the nature of lancets for the collection of blood for use in testing and for monitoring various medical conditionsalso including instructions and return shipping packaging; Testing kits containing medical laboratory research instruments for taking samples of human blood and body fluids for use in detecting cancer and other prenatalcardiovascular and autoimmunity anomaliesdisorders and diseases
Class 42
Providing medical research information regarding results of testing for various medical conditions; Providing scientific analysis and information regarding the results of laboratory testing in the field of various medical conditions; Laboratory testing servicesclinical processing of medical diagnostic testing kits; Medical research; Scientific research for medical purposes in the field of cancer and other prenatalcardiovascular and autoimmunity anomaliesdisorders and diseases; Providing temporary use of non-downloadable software for use in creatingdisplayingsharing and storing informationtest results and data in the fields of cancer and other prenatalcardiovascular and autoimmunity anomaliesdisorders and diseases; Providing online computer databases featuring medical research information in the fields of cancer and other prenatalcardiovascular and autoimmunity anomaliesdisorders and diseases
Class 44
Medical testing for diagnostic or treatment purposes; Medical diagnostic testingmonitoringreporting services; Consulting services in the fields of diagnostic medical testing; Providing medical informationconsultancy and advisory services; Providing medical testing services and information in the fields of cancer and other prenatalcardiovascular and autoimmunity anomaliesdisorders and diseases for diagnostic or treatment purposes; Medical testing servicesdiagnostic testing services for detecting cancer and other prenatalcardiovascular and autoimmunity anomaliesdisorders and diseases by identifying and analyzing biomarkers for diagnostic or treatment purposes; Providing screeningdetectionmonitoring services for cancer and other prenatalcardiovascular and autoimmunity anomaliesdisorders and diseases
Publications
History of USPTO decisions and trademark events.
41 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/03/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/14/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/14/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/04/2025
IUAF
USE AMENDMENT FILED
12/03/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/03/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/30/2025
EX5G
SOU EXTENSION 5 GRANTED
10/29/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/29/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/02/2025
EXT5
SOU EXTENSION 5 FILED
06/01/2025
EX4G
SOU EXTENSION 4 GRANTED
11/04/2024
EXT4
SOU EXTENSION 4 FILED
11/04/2024
EEXT
SOU TEAS EXTENSION RECEIVED
11/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/13/2024
EX3G
SOU EXTENSION 3 GRANTED
06/05/2024
EXT3
SOU EXTENSION 3 FILED
06/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/05/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/05/2023
EX2G
SOU EXTENSION 2 GRANTED
12/02/2023
EXT2
SOU EXTENSION 2 FILED
12/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/07/2023
EX1G
SOU EXTENSION 1 GRANTED
06/05/2023
EXT1
SOU EXTENSION 1 FILED
06/05/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/05/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/06/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/11/2022
PUBO
PUBLISHED FOR OPPOSITION
10/11/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/21/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/01/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/02/2022
GNRT
NON-FINAL ACTION E-MAILED
03/02/2022
CNRT
NON-FINAL ACTION WRITTEN
03/02/2022
DOCK
ASSIGNED TO EXAMINER
02/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2021
NWAP
NEW APPLICATION ENTERED
12/10/2021
Continuous trademark protection
Get notified about every new filing that threatens A or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.